BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

Trial Profile

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Osteoarthritis; Pain
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 11 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 16 Jun 2016 The trial was completed in Czech Republic (end date: 07-03-2016).
    • 08 Jun 2016 This trial was completed in Denmark (end date: 07-03-2016), according to European Clinical Trials Database
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top